Patents by Inventor Kenneth David Becker

Kenneth David Becker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin
    Publication number: 20040067512
    Abstract: The present invention is related to the discovery of several single nucleotide polymorphisms (SNPs) and/or mutations in the Alpha-2-Macroglobulin gene (A2M), which are risk factors for Alzheimer's Disease (AD). More specifically, aspects of the invention concern nucleic acids corresponding to the A2M gene or fragments thereof, which contain one or more of the SNPs and/or mutations described herein, peptides or proteins encoded by said nucleic acids, antibodies to said peptides or proteins and methods of making said compositions, diagnostic methods, methods of data analysis, and pharmaceutical discovery and preparation methods.
    Type: Application
    Filed: June 26, 2003
    Publication date: April 8, 2004
    Applicants: Neurogenetics, Inc., The General Hospital Corporation
    Inventors: Kenneth David Becker, Gonul Velicelebi, Xin Wang, Lars Bertram, Aleister J. Saunders, Rudolph E. Tanzi
  • Genes and polymorphisms on chromosome 10 associated with Alzheimer's disease and other neurodegenerative diseases
    Publication number: 20030224380
    Abstract: Probes, primers and kits for detection of polymorphisms in genes involved in neurodegenerative disease are provided. Methods based on detecting such polymorphisms for prognosticating, determining the occurrence, profiling drug response and drug discovery are also provided.
    Type: Application
    Filed: October 25, 2002
    Publication date: December 4, 2003
    Applicant: The General Hospital Corporation
    Inventors: Kenneth David Becker, Gonul Velicelebi, Kathryn J. Ellliott, Xin Wang, Rudolph E. Tanzi, Lars Bertram, Aleister J. Saunders, Kristina M. Mullin, Andrew Joseph Sampson
  • Genetic markers for Alzheimer's disease and methods using the same
    Publication number: 20030170678
    Abstract: Genetic markers associated with Alzheimer's disease are provided. Also provided are methods of determining the presence or absence in a subject of one or more polymorphisms associated with Alzheimer's disease and methods of determining the level of risk for Alzheimer's disease in a subject. Further provided are nucleic acid compositions and kits for use in determining the presence or absence in a subject of one or more polymorphisms associated with Alzheimer's disease and kits for determining the level of risk for Alzheimer's disease in a subject.
    Type: Application
    Filed: October 25, 2002
    Publication date: September 11, 2003
    Applicant: Neurogenetics, Inc.
    Inventors: Rudolph E. Tanzi, Kenneth David Becker, Gonul Velicelebi, Kathryn J. Elliott, Xin Wang, Lars Bertram, Aleister J. Saunders, Deborah Lynne Blacker
  • Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin
    Publication number: 20030162202
    Abstract: The present invention is related to the discovery of several single nucleotide polymorphisms (SNPs) and/or mutations in the Alpha-2-Macroglobulin gene (A2M), which are risk factors for Alzheimer's Disease (AD). More specifically, aspects of the invention concern nucleic acids corresponding to the A2M gene or fragments thereof, which contain one or more of the SNPs and/or mutations described herein, peptides or proteins encoded by said nucleic acids, antibodies to said peptides or proteins and methods of making said compositions, diagnostic methods, methods of data analysis, and pharmaceutical discovery and preparation methods.
    Type: Application
    Filed: November 8, 2002
    Publication date: August 28, 2003
    Inventors: Kenneth David Becker, Gonul Velicelebi, Xin Wang, Lars Bertram, Aleister J. Saunders, Rudolph E. Tanzi